Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
4.520
+0.320 (7.62%)
Nov 21, 2024, 11:23 AM EST - Market open
Telomir Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
133.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTELO News
- 4 hours ago - Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1 - Accesswire
- 7 weeks ago - Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday - Accesswire
- 2 months ago - Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications - Accesswire
- 3 months ago - Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - Accesswire
- 3 months ago - Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman - GlobeNewsWire
- 5 months ago - Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes - GlobeNewsWire
- 5 months ago - Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel - GlobeNewsWire
- 6 months ago - Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1 - GlobeNewsWire